|
|
||||||||||||||
|
|
|||||||||||||||
REVIEW |
Correspondence to:
Professor S Syrjänen
Department of Oral Pathology, Institute of Dentistry, Faculty of Medicine, University of Turku, Lemminkäisenkatu 2, FIN-20520 Turku, Finland; stina.syrjanen{at}utu.fi
ABSTRACT
Since human papillomavirus (HPV) was first linked to laryngeal/oral carcinomas in 1983, several studies have confirmed its causal role in a subgroup of upper aerodigestive tract tumours. Of the non-genital cancers, tonsillar carcinomas (TCs) have the strongest association with HPV. By the end of 2002, 432 TCs had been analysed for HPV DNA. Overall detection rate was 51%, with HPV-16 being the most prevalent (84%). The original proposal that HPV-33 would be the most frequent HPV in TCs has not been confirmed, being present in only 4.6% of cases. HPV copy numbers are similar to those found in genital carcinomas (10300 copies/cell), although HPV is mainly episomal in TC. The importance of this observation is unclear, although a role for subepithelial proliferative lymphatic tissue has been speculated. Patients with HPV-16 positive tumours have better overall and disease specific survival than HPV negative patients. They are also younger and the association with conventional risk factorssmoking and drinkingis less significant than in HPV negative patients. Thus, recent data suggest a distinct pattern for HPV-16 positive TCs.
Abbreviations: CI, confidence interval; HPV, human papillomavirus; ICD, international classification of diseases; ORF, open reading frame; SCC, squamous cell carcinoma
Keywords: human papillomavirus; tonsil cancer; tonsillar; tonsillar carcinoma; tonsils
This article has been cited by other articles:
![]() |
S. Syrjanen Human Papillomaviruses in Head and Neck Carcinomas N. Engl. J. Med., May 10, 2007; 356(19): 1993 - 1995. [Full Text] [PDF] |
||||
![]() |
B Perez-Ordonez, M Beauchemin, and R C K Jordan Molecular biology of squamous cell carcinoma of the head and neck. J. Clin. Pathol., May 1, 2006; 59(5): 445 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Laurie, J. C. Bell, H. L. Atkins, J. Roach, M. K. Bamat, J. D. O'Neil, M. S. Roberts, W. S. Groene, and R. M. Lorence A Phase 1 Clinical Study of Intravenous Administration of PV701, an Oncolytic Virus, Using Two-Step Desensitization Clin. Cancer Res., April 15, 2006; 12(8): 2555 - 2562. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Chen, P. Sehr, T. Waterboer, I. Leivo, M. Pawlita, A. Vaheri, and L.-M. Aaltonen Presence of DNA of Human Papillomavirus 16 but No Other Types in Tumor-Free Tonsillar Tissue J. Clin. Microbiol., March 1, 2005; 43(3): 1408 - 1410. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| Journal of Clinical Pathology | Molecular Pathology |